Drug intelligence / Profile preview

UI066

Development stage
Preclinical
Lead developer
Korea United Pharm
Modality
Small Molecules
Administration
Oral
01

Overview

UI066 is an incrementally modified drug (IMD) developed by Korea United Pharm, consisting of a controlled-release formulation of the small molecule vasodilator beraprost sodium. Beraprost is a synthetic analog of prostacyclin (PGI2) that acts as a potent vasodilator and inhibitor of platelet aggregation by serving as an agonist at the prostacyclin receptor (PTGIR). The controlled-release delivery system of UI066 is designed to maintain stable plasma concentrations of the drug over an extended period, which aims to improve therapeutic efficacy and patient compliance while minimizing side effects associated with the peak-to-trough fluctuations of immediate-release formulations. It is primarily intended for the treatment of vascular conditions such as peripheral arterial disease and potentially pulmonary arterial hypertension.

Other names
beraprost sodium sustained releaseberaprost sodium controlled release

Beyond the preview

Go deeper on UI066.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UI066.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call